Memory CD8+ T cell responses to cancer

被引:112
|
作者
Han, Jichang [1 ]
Khatwani, Nikhil [1 ]
Searles, Tyler G. [2 ]
Turk, Mary Jo [1 ,2 ]
Angeles, Christina, V [3 ,4 ]
机构
[1] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA
[2] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA
[3] Univ Michigan, Sch Med, Dept Surg, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Comprehens Canc Ctr, Ann Arbor, MI 48109 USA
关键词
Resident memory (T-RM); Stem cell memory (T-SCM); Effector memory (T-EM); Central memory (T-CM); Tumor immunity; Exhaustion; TISSUE-RESIDENT MEMORY; TUMOR-INFILTRATING LYMPHOCYTES; STEM-CELLS; CUTTING EDGE; IN-VIVO; NONLYMPHOID TISSUES; PROGNOSTIC-FACTOR; IMMUNE-RESPONSE; EFFECTOR; DIFFERENTIATION;
D O I
10.1016/j.smim.2020.101435
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Long-lived memory CD8(+) T cells play important roles in tumor immunity. Studies over the past two decades have identified four subsets of memory CD8(+) T cells - central, effector, stem-like, and tissue resident memory - that either circulate through blood, lymphoid and peripheral organs, or reside in tissues where cancers develop. In this article, we will review studies from both pre-clinical mouse models and human patients to summarize the phenotype, distribution and unique features of each memory subset, and highlight specific roles of each subset in anti-tumor immunity. Moreover, we will discuss how stem-cell like and resident memory CD8(+) T cell subsets relate to exhausted tumor-infiltrating lymphocytes (TIL) populations. These studies reveal how memory CD8(+) T cell subsets together orchestrate durable immunity to cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] The Tpm Subset of the CD8+ T Cell Memory Family
    Alegre, Maria-Luisa
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (04) : 849 - 849
  • [32] Viral vectors for inducing CD8+ T cell responses
    Truckenmiller, ME
    Norbury, CC
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2004, 4 (06) : 861 - 868
  • [33] Human influenza viruses and CD8+ T cell responses
    Grant, Emma J.
    Quinones-Parra, Sergio M.
    Clemens, E. Bridie
    Kedzierska, Katherine
    CURRENT OPINION IN VIROLOGY, 2016, 16 : 132 - 142
  • [34] GSDMD is required for effector CD8+ T cell responses to lung cancer cells
    Xi, Guangmin
    Gao, Jianwei
    Wan, Bing
    Zhan, Ping
    Xu, Wujian
    Lv, Tangfeng
    Song, Yong
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 74
  • [35] Unravelling the mechanisms of help for CD8+ T cell responses
    Alexandra M. Livingstone
    Elizabeth B. Wilson
    Fernando Ontiveros
    Jyh-Chiang E. Wang
    Immunologic Research, 2009, 45 : 209 - 217
  • [36] CD8+ T cell metabolism in infection and cancer
    Reina-Campos, Miguel
    Scharping, Nicole E.
    Goldrath, Ananda W.
    NATURE REVIEWS IMMUNOLOGY, 2021, 21 (11) : 718 - 738
  • [37] CD8+ T cell differentiation and dysfunction in cancer
    Mary Philip
    Andrea Schietinger
    Nature Reviews Immunology, 2022, 22 : 209 - 223
  • [38] CD8+ T cell tolerance and cancer immunotherapy
    de Visser, KE
    Schumacher, TNM
    Kruisbeek, AM
    JOURNAL OF IMMUNOTHERAPY, 2003, 26 (01) : 1 - 11
  • [39] CD8+ T cell metabolism in infection and cancer
    Miguel Reina-Campos
    Nicole E. Scharping
    Ananda W. Goldrath
    Nature Reviews Immunology, 2021, 21 : 718 - 738
  • [40] CD8+ T cell differentiation and dysfunction in cancer
    Philip, Mary
    Schietinger, Andrea
    NATURE REVIEWS IMMUNOLOGY, 2022, 22 (04) : 209 - 223